Study: Adalimumab can remain in newborn's bloodstream for at least three months
Links shared publicly online about this topic.
- 306total visits
Study: Adalimumab can remain in newborn's bloodstream for at least three months
View full resource at news-medical.net
Tags: Crohn's Disease Medication, Rheumatoid Arthritis Medication, Drug, Children's Health, Pregnancy, Humira, News
Most Recently Shared on May 9, 2011 at 9:53 am By:
Pregnancy News: Study: Adalimumab can remain in newborn's bloodstream for at least three months: Adalimumab, a d... http://bit.ly/jXr3MG
Adalimumab Levels Detected In Cord Blood And Infants Exposed In Utero - QualityPoint Technologies
qualitypointtech.net — “Adalimumab (ADA), a drug often prescribed for women with Crohn's disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn's bloodstream for at least three months, researchers at the University of California San Francisco have found. The new study has implications for pregnant women and their obstetricians and pediatricians because ADA is known to decrease the immune system's ability to fight infection...” View full resource at qualitypointtech.net
Most Recently Shared on May 8, 2011 at 8:45 am By:
Adalimumab Levels Detected In Cord Blood And Infants Exposed In Utero: Adalimumab (ADA), a drug often prescribed f... http://bit.ly/mh2WvI
Advertisement
